Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

A man's gray hair got darker and thicker after using a psoriasis drug.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

TNF-alpha inhibitors can cause various immune-related skin issues.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Blocking certain immune signals can reduce skin damage from radiation therapy.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.